{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "42"
        },
        "variant_string_id": "Parkin R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The Parkinson's disease-associated ubiquitin-protein ligase, Parkin, is important in the elimination of damaged mitochondria by autophagy (mitophagy) in a multistep process.",
          "judgment": "Yes",
          "reasoning": "The paper indicates that Parkin is important for mitophagy, which is linked to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper investigates the ability of Parkin mutants to induce mitophagy.",
          "judgment": "Yes",
          "reasoning": "Mitophagy induction directly relates to the disease mechanism, making this assay applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The expression of wild-type Parkin [FLAG-Parkin(WT)] and the disease-related Parkin mutants FLAG-Parkin(R42P) were compared in SK-N-SH neuroblastoma cells. SK-N-SH cells express low levels of endogenous Parkin compared with SH-SY-5Y cells",
          "judgment": "Yes",
          "reasoning": "Wild type Parkin was used as a normal control. They also used cells with low endogenous Parkin."
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Immunocytochemistry revealed that Parkin(WT) localized predominantly to the cytoplasm of cells (Fig. 1). In a minority (5%) of cells, FLAG-Parkin(WT) formed small cytoplasmic inclusions. Mitochondrial dynamics were assessed over time (Fig. 1, Supplementary Material, Fig. S3).",
          "judgment": "Yes",
          "reasoning": "Normal/Negative/Wild type controls were used (Parkin(WT)) and multiple replicates were indicated."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Parkin(C289G) was also tested",
          "judgment": "No",
          "reasoning": "The C289G variant is another disease related variant. There is no benign control variant used or a variant known to reach P/LP without PS3/BS3 evidence."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The FLAG-Parkin(R42P) mutant, which carries a mutation in Parkin's Ubl domain, was expressed at levels similar to Parkin(WT), but showed a tendency to misfold. Indeed, Parkin(R42P) aggregated into multiple small perinuclear inclusions in approximately 22% of cells (P < 0.05 compared with WT) and more was present in the pellet fraction",
          "judgment": "No",
          "reasoning": "Statistical analyses were performed (P < 0.05), but the p-value does not allow for calculation of OddsPath or sufficient estimation. Move to 4b."
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "They have one pathogenic control and wild type control.",
          "judgment": "N/A",
          "reasoning": "Only one pathogenic variant control (C289G) was used in addition to the wild-type, which is far less than 11 pathogenic/benign controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "R42P showed a reduced ability to prevent mitochondrial clustering following CCCP treatment. Since the study included basic controls and replicates, but no known pathogenic/benign controls, the functional evidence is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "Parkin C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The Parkinson's disease-associated ubiquitin-protein ligase, Parkin, is important in the elimination of damaged mitochondria by autophagy (mitophagy) in a multistep process.",
          "judgment": "Yes",
          "reasoning": "The paper indicates that Parkin is important for mitophagy, which is linked to Parkinson's disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper investigates the ability of Parkin mutants to induce mitophagy.",
          "judgment": "Yes",
          "reasoning": "Mitophagy induction directly relates to the disease mechanism, making this assay applicable."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The expression of wild-type Parkin [FLAG-Parkin(WT)] and the disease-related Parkin mutants FLAG-Parkin(C289G) were compared in SK-N-SH neuroblastoma cells.",
          "judgment": "Yes",
          "reasoning": "Wild type Parkin was used as a normal control."
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Immunocytochemistry revealed that Parkin(WT) localized predominantly to the cytoplasm of cells (Fig. 1). In a minority (5%) of cells, FLAG-Parkin(WT) formed small cytoplasmic inclusions. Mitochondrial dynamics were assessed over time (Fig. 1, Supplementary Material, Fig. S3).",
          "judgment": "Yes",
          "reasoning": "Normal/Negative/Wild type controls were used (Parkin(WT)) and multiple replicates were indicated."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "R42P variant was also tested.",
          "judgment": "No",
          "reasoning": "The R42P variant is another disease related variant. There is no benign control variant used or a variant known to reach P/LP without PS3/BS3 evidence."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The RING1 domain mutant FLAG-Parkin(C289G) failed to stimulate mitochondrial clustering (21% after 6h of CCCP treatment)",
          "judgment": "No",
          "reasoning": "Statistical analyses were performed (P < 0.05), but the p-value does not allow for calculation of OddsPath or sufficient estimation. Move to 4b."
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "They have one pathogenic control and wild type control.",
          "judgment": "N/A",
          "reasoning": "Only one pathogenic variant control (R42P) was used in addition to the wild-type, which is far less than 11 pathogenic/benign controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "C289G showed a reduced ability to prevent mitochondrial clustering following CCCP treatment. Since the study included basic controls and replicates, but no known pathogenic/benign controls, the functional evidence is PS3_supporting."
    }
  ]
}
